Paraneoplastic dermatomyositis preceding detection of metastatic oesophageal squamous cell carcinoma after prolonged remission following pembrolizumab therapy.

BMJ Case RepOct 1, 2026 (epub)

Syed Adil Hassan, Kasturi Hazarika, Prashant Kumar Rai

✦ AI-curated · Sources linked

Case in brief

A man in his late fifties with a history of treated oesophageal squamous cell carcinoma developed severe dermatomyositis after six years of remission. He presented with progressive muscle weakness, dysphagia, and elevated creatine kinase levels. Imaging revealed metastatic disease in the thoracic oesophagus, lymph nodes, and liver. Treatment with corticosteroids and chemotherapy led to significant improvement in both his symptoms and tumor burden.

What made this case unusual

This case highlights the development of dermatomyositis after a prolonged remission from oesophageal squamous cell carcinoma, which is an uncommon association.

Diagnostic / clinical pearl

Clinicians should consider paraneoplastic syndromes like dermatomyositis in patients with a history of malignancy who present with new inflammatory myopathy.

Why it matters

Recognizing the potential for paraneoplastic manifestations after long-term remission can aid in early detection of recurrent malignancy.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.